This is a short correspondence (received Feb 8, accepted Feb 17, 2022) responding to the Kang et al. case report of a 32-year-old healthy male with aseptic meningitis after a second BNT162b2 dose . The letter makes two defensible critical points: (1) the case report provided no pre-vaccination immune or neurological status, so inferring causality is difficult, and (2) a concurrent infection such as dengue β which can itself cause aseptic meningitis β was not laboratory-excluded . A prior Japanese case (42-year-old nurse) similarly noted lymphocytic CSF pleocytosis (528/3 mmΒ³) without establishing mechanism .
Critique: The letter itself is speculation without new data β it invokes dengue purely as a theoretical confounder, and its own cited reply acknowledges dengue testing was not performed, relying only on travel history . Both the original case and this letter are n=1, uncontrolled, and cannot separate coincidence, immune-mediated reaction, and undiagnosed infection. The letter correctly flags a real epistemic gap but adds no falsifying evidence itself.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.